Getting Back to Normal: Can Enhanced Regeneration Maintain Health?
From the Duke Clinical Research Institute (DCRI) and Department of Medicine, Duke Medicine, Durham, NC (T.J.P.); Caladrius Biosciences, Basking Ridge, NJ (D.W.L.); Division of Cardiology, Department of Medicine, Northwestern University School of Medicine, Chicago, IL (D.W.L.); and New York University School of Medicine, NY (D.W.L.). Thomas.Povsic@duke.edu dlosordo@caladrius.com.
Thomas J
TJ
Povsic
From the Duke Clinical Research Institute (DCRI) and Department of Medicine, Duke Medicine, Durham, NC (T.J.P.); Caladrius Biosciences, Basking Ridge, NJ (D.W.L.); Division of Cardiology, Department of Medicine, Northwestern University School of Medicine, Chicago, IL (D.W.L.); and New York University School of Medicine, NY (D.W.L.). Thomas.Povsic@duke.edu dlosordo@caladrius.com.
Douglas W
DW
Losordo
D018952:Antigens, CD34 / Q000032:analysis; D011446:Prospective Studies; D012038:Regeneration; D013234:Stem Cells / Q000737:chemistry*
D018952:Antigens, CD34
CD34+ cells; Editorials; bone marrow; endothelial progenitor cells; immune tolerance; stem cells; type 1 diabetes mellitus